D. Swaab, E. Fliers, and T. Partiman, The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia, Brain Research, vol.342, issue.1, pp.37-44, 1985.
DOI : 10.1016/0006-8993(85)91350-2

J. Evans and A. Davidson, Health Consequences of Circadian Disruption in Humans and Animal Models, Prog Mol Biol Transl Sci, vol.119, pp.283-323, 2013.
DOI : 10.1016/B978-0-12-396971-2.00010-5

P. Innominato, S. Giacchetti, G. Bjarnason, C. Focan, C. Garufi et al., Prediction of overall survival through circadian rest-activity monitoring during chemotherapy for metastatic colorectal cancer, International Journal of Cancer, vol.8, issue.Suppl 3, pp.2684-92, 2012.
DOI : 10.1002/ijc.27574

P. Innominato, C. Focan, T. Gorlia, T. Moreau, C. Garufi et al., Circadian Rhythm in Rest and Activity: A Biological Correlate of Quality of Life and a Predictor of Survival in Patients with Metastatic Colorectal Cancer, Cancer Research, vol.69, issue.11, pp.4700-4707, 2009.
DOI : 10.1158/0008-5472.CAN-08-4747

M. Mormont, J. Waterhouse, P. Bleuzen, S. Giacchetti, J. A. Bogdan et al., Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status, Clin Cancer Res, vol.6, pp.3038-3083, 2000.

K. Straif, R. Baan, Y. Grosse, B. Secretan, E. Ghissassi et al., Carcinogenicity of shift-work, painting, and fire-fighting, The Lancet Oncology, vol.8, issue.12, pp.1065-1071, 2007.
DOI : 10.1016/S1470-2045(07)70373-X

E. Ortiz-tudela, A. Mteyrek, A. Ballesta, P. Innominato, and F. Lévi, Cancer Chronotherapeutics: Experimental, Theoretical, and Clinical Aspects, Handb Exp Pharmacol, issue.217, pp.261-88, 2013.
DOI : 10.1007/978-3-642-25950-0_11

F. Lévi and A. Okyar, Circadian clocks and drug delivery systems: impact and opportunities in chronotherapeutics, Expert Opinion on Drug Delivery, vol.8, issue.12, pp.1535-1576, 2011.
DOI : 10.1200/JCO.2003.10.083

D. Rahn-3rd, D. Ray, D. Schlesinger, L. Steiner, J. Sheehan et al., Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: Is there a difference in outcome between morning and afternoon treatment?, Cancer, vol.106, issue.2, pp.414-434, 2011.
DOI : 10.1002/cncr.25423

K. Schmiegelow, A. Glomstein, J. Kristinsson, T. Salmi, H. Schrøder et al., Impact of Morning Versus Evening Schedule for Oral Methotrexate and 6-Mercaptopurine on Relapse Risk for Children with Acute Lymphoblastic Leukemia, Journal of Pediatric Hematology/Oncology, vol.19, issue.2
DOI : 10.1097/00043426-199704000-00002

F. Lévi, A. Okyar, S. Dulong, P. Innominato, and J. Clairambault, Circadian Timing in Cancer Treatments, Annual Review of Pharmacology and Toxicology, vol.50, issue.1, pp.377-421, 2010.
DOI : 10.1146/annurev.pharmtox.48.113006.094626

E. Ortiz-tudela, I. Iurisci, J. Beau, A. Karaboue, T. Moreau et al., The circadian rest-activity rhythm, a potential safety pharmacology endpoint of cancer chemotherapy, International Journal of Cancer, vol.102, issue.11, pp.2717-2742, 2014.
DOI : 10.1002/ijc.28587

S. Giacchetti, P. Dugué, P. Innominato, G. Bjarnason, C. Focan et al., Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis, Annals of Oncology, vol.23, issue.12, pp.3110-3116, 2012.
DOI : 10.1093/annonc/mds148

S. Giacchetti, G. Bjarnason, C. Garufi, D. Genet, S. Iacobelli et al., Phase III Trial Comparing 4-Day Chronomodulated Therapy Versus 2-Day Conventional Delivery of Fluorouracil, Leucovorin, and Oxaliplatin As First-Line Chemotherapy of Metastatic Colorectal Cancer: The European Organisation for Research and Treatment of Cancer Chronotherapy Group, Journal of Clinical Oncology, vol.24, issue.22, pp.3562-3571, 2006.
DOI : 10.1200/JCO.2006.06.1440

A. Adan and V. Natale, GENDER DIFFERENCES IN MORNINGNESS???EVENINGNESS PREFERENCE, Chronobiology International, vol.14, issue.2, pp.709-729, 2002.
DOI : 10.1177/074873099129000911

J. Duffy, S. Cain, A. Chang, A. Phillips, M. Münch et al., Sex difference in the near-24-hour intrinsic period of the human circadian timing system, Proceedings of the National Academy of Sciences, vol.108, issue.Supplement_3, pp.15602-15610, 2011.
DOI : 10.1073/pnas.1010666108

T. Roenneberg, T. Kantermann, M. Juda, C. Vetter, and K. Allebrandt, Light and the Human Circadian Clock, Handb Exp Pharmacol, issue.217, pp.311-342, 2013.
DOI : 10.1007/978-3-642-25950-0_13

T. Roenneberg, T. Kuehnle, M. Juda, T. Kantermann, K. Allebrandt et al., Epidemiology of the human circadian clock, Sleep Medicine Reviews, vol.11, issue.6, pp.429-467, 2007.
DOI : 10.1016/j.smrv.2007.07.005

J. Vink, A. Groot, G. Kerkhof, and D. Boomsma, GENETIC ANALYSIS OF MORNINGNESS AND EVENINGNESS, Chronobiology International, vol.409, issue.3, pp.809-831, 2001.
DOI : 10.1016/0896-6273(95)90086-1

S. Ancoli-israel, R. Cole, C. Alessi, M. Chambers, W. Moorcroft et al., The role of actigraphy in the study of sleep and circadian rhythms, Sleep, vol.26, pp.342-92, 2003.

A. Sadeh and C. Acebo, The role of actigraphy in sleep medicine, Sleep Medicine Reviews, vol.6, issue.2, pp.113-137, 2002.
DOI : 10.1053/smrv.2001.0182

K. Kräuchi, How is the circadian rhythm of core body temperature regulated?, Clinical Autonomic Research, vol.12, issue.3, pp.147-156, 2002.
DOI : 10.1007/s10286-002-0043-9

J. Waterhouse, B. Drust, D. Weinert, B. Edwards, W. Gregson et al., The Circadian Rhythm of Core Temperature: Origin and some Implications for Exercise Performance, Chronobiology International, vol.41, issue.2, pp.207-232, 2005.
DOI : 10.1081/CBI-120018649

A. Martinez-nicolas, E. Ortiz-tudela, J. Madrid, and M. Rol, Crosstalk Between Environmental Light and Internal Time in Humans, Chronobiology International, vol.37, issue.7, pp.617-646, 2011.
DOI : 10.3109/07420529908998724

E. Ortiz-tudela, A. Martinez-nicolas, M. Campos, M. Rol, and J. Madrid, A New Integrated Variable Based on Thermometry, Actimetry and Body Position (TAP) to Evaluate Circadian System Status in Humans, PLoS Computational Biology, vol.15, issue.11, p.1000996, 2010.
DOI : 10.1371/journal.pcbi.1000996.t003

J. Sarabia, M. Rol, P. Mendiola, and J. Madrid, Circadian rhythm of wrist temperature in normal-living subjects, Physiology & Behavior, vol.95, issue.4, pp.570-80, 2008.
DOI : 10.1016/j.physbeh.2008.08.005

A. Martinez-nicolas, E. Ortiz-tudela, M. Rol, and J. Madrid, Uncovering Different Masking Factors on Wrist Skin Temperature Rhythm in Free-Living Subjects, PLoS ONE, vol.278, issue.4, p.61142, 2013.
DOI : 10.1371/journal.pone.0061142.g005

. Thermometry, Activity and body Position (TAP): A comparison with polysomnography, Physiol Behav, vol.126, pp.30-38, 2014.

M. Bonmati-carrion, B. Middleton, V. Revell, D. Skene, M. Rol et al., Circadian phase asessment by ambulatory monitoring in humans: Correlation with dim light melatonin onset, Chronobiology International, vol.12, issue.1, pp.37-51, 2013.
DOI : 10.3109/07420529908998721

F. Lévi, C. Focan, A. Karaboué, V. De-la-valette, D. Focan-henrard et al., Implications of circadian clocks for the rhythmic delivery of cancer therapeutics, Adv Drug Deliv Rev, vol.59, pp.9-101015, 2007.

C. Garufi, B. Vanni, A. Aschelter, A. Zappalà, E. Bria et al., Randomised phase II study of standard versus chronomodulated CPT-11 plus chronomodulated 5-fluorouracil and folinic acid in advanced colorectal cancer patients, European Journal of Cancer, vol.42, issue.5, pp.608-624, 2006.
DOI : 10.1016/j.ejca.2005.03.012

D. Gholam, S. Giacchetti, C. Brézault-bonnet, M. Bouchahda, D. Hauteville et al., Chronomodulated Irinotecan, Oxaliplatin, and Leucovorin-Modulated 5-Fluorouracil as Ambulatory Salvage Therapy in Patients with Irinotecan- and Oxaliplatin-Resistant Metastatic Colorectal Cancer, The Oncologist, vol.11, issue.10, pp.1072-80, 2006.
DOI : 10.1634/theoncologist.11-10-1072

P. Innominato, S. Giacchetti, T. Moreau, G. Bjarnason, R. Smaaland et al., Fatigue and weight loss predict survival on circadian chemotherapy for metastatic colorectal cancer, Cancer, vol.36, issue.14, pp.2564-73, 2013.
DOI : 10.1002/cncr.28072

E. Van-someren, D. Swaab, C. Colenda, W. Cohen, W. Mccall et al., Bright Light Therapy: Improved Sensitivity to Its Effects on Rest-Activity Rhythms in Alzheimer Patients by Application of Nonparametric Methods, Chronobiology International, vol.8, issue.1, pp.505-523, 1999.
DOI : 10.1016/0361-9230(93)90053-E

T. Erren and R. Reiter, Defining chronodisruption, Journal of Pineal Research, vol.60, issue.3, pp.245-252, 2009.
DOI : 10.1111/j.1600-079X.2009.00665.x

S. Ancoli-israel, L. Liu, M. Marler, B. Parker, V. Jones et al., Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer, Supportive Care in Cancer, vol.13, issue.4, pp.201-210, 2006.
DOI : 10.1007/s00520-005-0861-0

A. Berger, L. Farr, B. Kuhn, P. Fischer, and S. Agrawal, Values of Sleep/Wake, Activity/Rest, Circadian Rhythms, and Fatigue Prior to Adjuvant Breast Cancer Chemotherapy, Journal of Pain and Symptom Management, vol.33, issue.4, pp.398-409, 2007.
DOI : 10.1016/j.jpainsymman.2006.09.022

A. Berger, K. Wielgus, M. Hertzog, P. Fischer, and L. Farr, Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy, Supportive Care in Cancer, vol.67, issue.6, pp.105-119, 2010.
DOI : 10.1007/s00520-009-0636-0

J. Savard, L. Liu, L. Natarajan, M. Rissling, A. Neikrug et al., Breast Cancer Patients have Progressively Impaired Sleep-Wake Activity Rhythms during Chemotherapy, Sleep, vol.32, pp.1155-60, 2009.

P. Innominato, V. Roche, O. Palesh, A. Ulusakarya, D. Spiegel et al., The circadian timing system in clinical oncology, Annals of Medicine, vol.85, issue.3, pp.191-207, 2014.
DOI : 10.1634/theoncologist.11-10-1072

F. Lévi, P. Dugué, P. Innominato, A. Karaboué, G. Dispersyn et al., Wrist actimetry circadian rhythm as a robust predictor of colorectal cancer patients survival, Chronobiology International, vol.75, issue.8, pp.891-900, 2014.
DOI : 10.3109/07420529609040839

O. Palesh, A. Aldridge-gerry, A. Ulusakarya, E. Ortiz-tudela, L. Capuron et al., Sleep disruption in breast cancer patients and survivors, J Natl Compr Canc Netw, vol.11, pp.1523-1553, 2013.

E. Ortiz-tudela, Crosstalk between sleep disturbances and cancer survival, Sleep Medicine, vol.16, issue.3, pp.1389-945700484, 2014.
DOI : 10.1016/j.sleep.2014.11.009

S. Sephton, E. Lush, E. Dedert, A. Floyd, W. Rebholz et al., Diurnal cortisol rhythm as a predictor of lung cancer survival, Brain, Behavior, and Immunity, vol.30, pp.163-70, 2013.
DOI : 10.1016/j.bbi.2012.07.019

S. Sephton, R. Sapolsky, H. Kraemer, and D. Spiegel, Diurnal Cortisol Rhythm as a Predictor of Breast Cancer Survival, Journal of the National Cancer Institute, vol.92, issue.12, pp.994-1000, 2000.
DOI : 10.1093/jnci/92.12.994

A. Schrepf, P. Thaker, M. Goodheart, D. Bender, G. Slavich et al., Diurnal cortisol and survival in epithelial ovarian cancer, Diurnal cortisol and survival in epithelial ovarian cancer, pp.256-67, 2015.
DOI : 10.1016/j.psyneuen.2015.01.010

E. Haus and M. Smolensky, Shift work and cancer risk: Potential mechanistic roles of circadian disruption, light at night, and sleep deprivation, Sleep Medicine Reviews, vol.17, issue.4, pp.273-84, 2013.
DOI : 10.1016/j.smrv.2012.08.003

E. Schernhammer, D. Feskanich, G. Liang, and J. Han, Rotating Night-Shift Work and Lung Cancer Risk Among Female Nurses in the United States, American Journal of Epidemiology, vol.178, issue.9, pp.1434-1475, 2013.
DOI : 10.1093/aje/kwt155

X. Li and F. Lévi, Circadian Physiology Is a Toxicity Target of the Anticancer Drug Gemcitabine in Mice, Journal of Biological Rhythms, vol.45, issue.2, pp.159-66, 2007.
DOI : 10.1177/0748730406298984

P. Innominato, S. Giacchetti, T. Moreau, R. Smaaland, C. Focan et al., Prediction of Survival by Neutropenia According To Delivery Schedule of Oxaliplatin???5-Fluorouracil???Leucovorin for Metastatic Colorectal Cancer in a Randomized International Trial (EORTC 05963), Chronobiology International, vol.97, issue.2, pp.586-600, 2011.
DOI : 10.1038/bjc.1992.213

D. Seely, P. Wu, H. Fritz, D. Kennedy, T. Tsui et al., Melatonin as Adjuvant Cancer Care With and Without Chemotherapy, Integrative Cancer Therapies, vol.20, issue.4, pp.293-303, 2012.
DOI : 10.1002/sim.1186

S. Ancoli-israel, M. Rissling, A. Neikrug, V. Trofimenko, L. Natarajan et al., Light treatment prevents fatigue in women undergoing chemotherapy for breast cancer, Supportive Care in Cancer, vol.22, issue.6, pp.1211-1220, 2012.
DOI : 10.1007/s00520-011-1203-z

X. Li, F. Delaunay, S. Dulong, B. Claustrat, S. Zampera et al., Cancer Inhibition through Circadian Reprogramming of Tumor Transcriptome with Meal Timing, Cancer Research, vol.70, issue.8, pp.3351-60, 2010.
DOI : 10.1158/0008-5472.CAN-09-4235

URL : https://hal.archives-ouvertes.fr/hal-00497206